First Trust Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.58M Sell
162,565
-136,907
-46% -$2.38M ﹤0.01% 1644
2025
Q4
$3.53M Buy
299,472
+189,946
+173% +$2.44M ﹤0.01% 1606
2025
Q3
$1.73M Sell
109,526
-454,665
-81% -$6.59M ﹤0.01% 1898
2025
Q2
$6.46M Buy
564,191
+207,092
+58% +$2.33M 0.01% 1241
2025
Q1
$4.83M Sell
357,099
-139,156
-28% -$2.31M ﹤0.01% 1328
2024
Q4
$8.39M Buy
496,255
+104,506
+27% +$2.03M 0.01% 1118
2024
Q3
$7.96M Buy
391,749
+90,493
+30% +$1.85M 0.01% 1119
2024
Q2
$6.8M Buy
301,256
+188,199
+166% +$4.93M 0.01% 1141
2024
Q1
$2.97M Sell
113,057
-16,843
-13% -$480K ﹤0.01% 1555
2023
Q4
$4.1M Sell
129,900
-383,646
-75% -$10.4M ﹤0.01% 1377
2023
Q3
$14.4M Sell
513,546
-180,732
-26% -$6.21M 0.02% 871
2023
Q2
$25.6M Sell
694,278
-798,188
-53% -$24.4M 0.03% 644
2023
Q1
$44.7M Buy
1,492,466
+109,667
+8% +$3.61M 0.05% 468
2022
Q4
$42.3M Sell
1,382,799
-172,922
-11% -$5.19M 0.05% 483
2022
Q3
$38.3M Sell
1,555,721
-187,319
-11% -$6.18M 0.05% 491
2022
Q2
$55.8M Buy
1,743,040
+428,752
+33% +$15.8M 0.07% 420
2022
Q1
$41.4M Buy
1,314,288
+895,847
+214% +$28M 0.04% 542
2021
Q4
$14M Sell
418,441
-298,633
-42% -$9.3M 0.01% 952
2021
Q3
$20.8M Buy
717,074
+148,257
+26% +$4.8M 0.02% 764
2021
Q2
$19.8M Buy
568,817
+454,806
+399% +$15.1M 0.02% 782
2021
Q1
$3.18M Sell
114,011
-46,308
-29% -$1.23M ﹤0.01% 1523
2020
Q4
$3.97M Buy
160,319
+89,432
+126% +$2.13M 0.01% 1200
2020
Q3
$1.48M Sell
70,887
-95,144
-57% -$1.84M ﹤0.01% 1539
2020
Q2
$2.55M Sell
166,031
-174,203
-51% -$2.2M ﹤0.01% 1265
2020
Q1
$3.02M Sell
340,234
-268,010
-44% -$3.86M 0.01% 1079
2019
Q4
$11M Buy
608,244
+429,442
+240% +$7.13M 0.02% 807
2019
Q3
$2.67M Buy
178,802
+40,368
+29% +$657K 0.01% 1362
2019
Q2
$3.32M Buy
138,434
+20,764
+18% +$612K 0.01% 1293
2019
Q1
$4.37M Buy
117,670
+33,696
+40% +$1.23M 0.01% 1095
2018
Q4
$2.37M Sell
83,974
-9,607
-10% -$304K 0.01% 1380
2018
Q3
$3.69M Sell
93,581
-298,519
-76% -$13.1M 0.01% 1310
2018
Q2
$17.4M Sell
392,100
-234,602
-37% -$11.7M 0.04% 620
2018
Q1
$30.5M Sell
626,702
-16,984
-3% -$849K 0.07% 353
2017
Q4
$32.2M Buy
643,686
+286,078
+80% +$15M 0.08% 330
2017
Q3
$18.1M Buy
357,608
+126,967
+55% +$5.99M 0.05% 556
2017
Q2
$8.75M Buy
230,641
+67,505
+41% +$2.66M 0.02% 795
2017
Q1
$6.28M Buy
163,136
+55,427
+51% +$1.67M 0.02% 953
2016
Q4
$2.38M Sell
107,709
-19,593
-15% -$402K 0.01% 1335
2016
Q3
$2.04M Buy
+127,302
New +$1.45M 0.01% 1328
2016
Q1
Sell
-795,983
Closed -$4.27M 2223
2015
Q4
$4.27M Buy
+795,983
New +$5.09M 0.01% 1028

Other funds holding CC

First Trust Advisors's CC Position: Q1 2026 in Review

First Trust Advisors reduced its Chemours (CC) stake by 46% in Q1 2026, selling an estimated $2.38M and leaving 162,565 shares worth $3.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1644.

First Trust Advisors first reported a position in CC in Q4 2015 and has held it in 40 quarters since. The position peaked at $55.8M in Q2 2022. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • First Trust Advisors held 162,565 shares of Chemours worth $3.58M as of Q1 2026.
  • First Trust Advisors sold 136,907 Chemours shares in Q1 2026, an estimated $2.38M.
  • Chemours made up ﹤0.01% of First Trust Advisors's portfolio in Q1 2026, its #1644 holding.
  • First Trust Advisors first reported a position in Chemours in Q4 2015 and has held it in 40 quarters since.
  • First Trust Advisors's Chemours position peaked at $55.8M in Q2 2022.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.